Literature DB >> 12399485

Proteins released by Helicobacter pylori in vitro.

Nayoung Kim1, David L Weeks, Jai Moo Shin, David R Scott, Mary K Young, George Sachs.   

Abstract

Secretion of proteins by Helicobacter pylori may contribute to gastric inflammation and epithelial damage. An in vitro analysis was designed to identify proteins released by mechanisms other than nonspecific lysis. The radioactivity of proteins in the supernatant was compared with that of the intact organism by two-dimensional gel phosphorimaging following a 4-h pulse-chase. The ratio of the amount of UreB, a known cytoplasmic protein, in the supernatant to that in the pellet was found to be 0.25, and this was taken as an index of lysis during the experiments (n = 6). Ratios greater than that of UreB were used to distinguish proteins that were selectively released into the medium. Thus, proteins enriched more than 10-fold in the supernatant compared to UreB were identified by mass spectrometry. Sixteen such proteins were present in the supernatant: VacA; a conserved secreted protein (HP1286); putative peptidyl cis-trans isomerase (HP0175); six proteins encoded by HP0305, HP0231, HP0973, HP0721, HP0129, and HP0902; thioredoxin (HP1458); single-stranded-DNA-binding 12RNP2 precursor (HP0827); histone-like DNA-binding protein HU (HP0835); ribosomal protein L11 (HP1202); a putative outer membrane protein (HP1564); and outer membrane proteins Omp21 (HP0913) and Omp20 (HP0912). All except HP0902, thioredoxin, HP0827, HP0835, and HP1202 had a signal peptide. When nalidixic acid, a DNA synthesis inhibitor, was added to inhibit cell division but not protein synthesis, to decrease possible contamination due to outer membrane shedding, two outer membrane proteins (Omp21 and Omp20) disappeared from the supernatant, and the amount of VacA also decreased. Thus, 13 proteins were still enriched greater than 10-fold in the medium after nalidixic acid treatment, suggesting these were released specifically, possibly by secretion. These proteins may be implicated in H. pylori-induced effects on the gastric epithelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399485      PMCID: PMC151949          DOI: 10.1128/JB.184.22.6155-6162.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  52 in total

1.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Mechanism and regulation of mRNA polyadenylation.

Authors:  D F Colgan; J L Manley
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

Review 4.  Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention.

Authors:  T L Cover; M J Blaser
Journal:  Adv Intern Med       Date:  1996

5.  Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.

Authors:  H Nielsen; J Engelbrecht; S Brunak; G von Heijne
Journal:  Protein Eng       Date:  1997-01

Review 6.  Determinants of Helicobacter pylori pathogenicity.

Authors:  A Labigne; H de Reuse
Journal:  Infect Agents Dis       Date:  1996-10

Review 7.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

8.  Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection.

Authors:  L A Noach; N B Bosma; J Jansen; F J Hoek; S J van Deventer; G N Tytgat
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

9.  Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.

Authors:  W Schmitt; R Haas
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

10.  Isolation and characterization of a family of porin proteins from Helicobacter pylori.

Authors:  M M Exner; P Doig; T J Trust; R E Hancock
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more
  31 in total

1.  Crystallization and X-ray data collection of HP0902 from Helicobacter pylori 26695.

Authors:  Dae Won Sim; Jung Hyun Song; Woo Cheol Lee; Yoo Sup Lee; Hye Yeon Kim; Hyung Sik Won
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-11-26

Review 2.  Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection.

Authors:  Brian Henderson; Elaine Allan; Anthony R M Coates
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 3.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea.

Authors:  Julia Butt; Matthew G Varga; Tianyi Wang; Shoichiro Tsugane; Taichi Shimazu; Wei Zheng; Christian C Abnet; Keun-Young Yoo; Sue K Park; Jeongseon Kim; Sun Ha Jee; You-Lin Qiao; Xiao-Ou Shu; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Cancer Prev Res (Phila)       Date:  2019-07-26

Review 5.  Structural and functional aspects of the Helicobacter pylori secretome.

Authors:  Giuseppe Zanotti; Laura Cendron
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

7.  Substrate specificity of Helicobacter pylori histone-like HU protein is determined by insufficient stabilization of DNA flexure points.

Authors:  Christina Chen; Sharmistha Ghosh; Anne Grove
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

8.  A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori.

Authors:  Hong Wu; Takashi Nakano; Yuji Matsuzaki; Yukimasa Ooi; Takehiro Kohno; Sonoko Ishihara; Kouichi Sano
Journal:  Med Mol Morphol       Date:  2014-01-14       Impact factor: 2.309

9.  Construction of a prokaryotic expression system of vacA gene and detection of vacA gene, VacA protein in Helicobacter pylori isolates and ant-VacA antibody in patients' sera.

Authors:  Jie Yan; Ya-Fei Mao
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

10.  Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Helicobacter pylori strain 26695.

Authors:  Seung-Chul Baik; Kyung-Mi Kim; Su-Min Song; Do-Su Kim; Jin-Su Jun; Seung-Gyu Lee; Jae-Young Song; Jeong-Uck Park; Hyung-Lyun Kang; Woo-Kon Lee; Myung-Je Cho; Hee-Shang Youn; Gyung-Hyuck Ko; Kwang-Ho Rhee
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.